Skip to main content

Day: June 27, 2022

With 14.9% CAGR, Online Dermatology Consultations Market Size to Surpass Around USD 7.38 Billion by 2029

According to Fortune Business Insights, Online Dermatology Consultations Market to Reach USD 7.38 Billion by 2029; Rising Incidences of Dermatological Conditions to Propel Growth Pune, India, June 27, 2022 (GLOBE NEWSWIRE) — The online dermatology consultations market size was valued at USD 2.44 billion in 2021. The market size is expected to rise from USD 2.80 billion in 2022 to USD 7.38 billion by 2029 at a CAGR of 14.9% during the projected period. Fortune Business Insights™ publishes this information in a report titled, “Online Dermatology Consultations Market, 2022-2029”. According to the report, the market is expected to rise during the forecast period due to increasing incidence of dermatological conditions. Key Industry Development:April 2021: Evernorth acquired MDLIVE to boost virtual care capabilities and...

Continue reading

Electric Vehicle Battery Swapping Market Size worth 641.0 Million, Globally, by 2028 at 27.1% CAGR

The global electric vehicle battery swapping market size is expected to grow from USD 119.4 Million in 2021 to USD 641.0 Million by 2028; it is estimated to grow at a CAGR of 27.1% from 2021 to 2028. Pune, India, June 27, 2022 (GLOBE NEWSWIRE) — The global electric vehicle battery swapping market size was USD 100.2 million in 2020. The market is projected to grow from USD 119.4 million 2021 to USD 641.0 million in 2028 at a CAGR of 27.1% during the 2021-2028 period. This vital information is presented by Fortune Business Insights™, in its report, titled, “Electric Vehicle Battery Swapping Market, 2021-2028.” Factors such as the ability to erase concerns such as longer charging times, range anxiety, and high battery replacement costs are expected to boost the market growth during the forecast period. Additionally, factors such...

Continue reading

Sydbank share buyback programme: transactions in week 25

        Company Announcement No 29/2022Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk27 June 2022  Dear Sirs Sydbank share buyback programme: transactions in week 25On 2 March 2022 Sydbank announced a share buyback programme of DKK 425m. The share buyback commenced on 7 March 2022 and will be completed by 30 December 2022. The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under the share buyback programme:  Number...

Continue reading

Industrial Waste Management Market Size Worth USD 1,434.98 Billion, Globally, by 2028 at 5.6% CAGR

The industrial waste management market size is expected to grow from USD 937.6 Billion in 2020 to USD 1,434.98 Billion by 2028; it is estimated to grow at a CAGR of 5.6% from 2021 to 2028. Pune, India, June 27, 2022 (GLOBE NEWSWIRE) — The global industrial waste management market size is expected to gain momentum by reaching USD 1,434.98 billion by 2028 while exhibiting a CAGR of 5.6% between 2021 to 2028. In its report titled “Industrial Waste Management Market, 2021-2028,” Fortune Business Insight mentions that the market stood at USD 937.6 billion in 2020. The rising construction and demolition waste, and manufacturing waste due to rapidly increasing infrastructure development around the world have severely impacted the environment. For instance, Abu Dhabi generates 42% of total solid waste due to construction and demolition...

Continue reading

Form 8.3 – Emis Group

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: Investec Wealth & Investment Limited(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeEmis Group Plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)        Date...

Continue reading

Change in Aspo’s Group Executive Committee

Aspo PlcStock exchange releaseJune 27, 2022 at 11:20 a.m. Change in Aspo’s Group Executive Committee Heli Arantola, Managing Director of Aspo’s subsidiary Leipurin, has resigned to join another company. Arantola will leave the company in December at the latest, and the process of selecting her successor has begun. “I thank Heli for her excellent contribution to the modernization of Leipurin and transforming the company in the rapidly changing bakery and food industry. I wish her the best of luck in her future endeavors,” says Rolf Jansson, CEO of Aspo Group. Aspo Plc Rolf JanssonCEO Further information, please contact: Rolf Jansson, CEO, Aspo Plc, +358 400 600 264, rolf.jansson@aspo.com DISTRIBUTION:Nasdaq Helsinki        Key mediawww.aspo.com Aspo creates value by owning and developing business operations sustainably and in the long...

Continue reading

Proactive news headlines including MGC Pharmaceuticals, Tamboran Resources, Surefire Resources and Latrobe Magnesium

Sydney, June 27, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has received preliminary results from a pre-clinical in-vitro study of CimetrA, indicating that it has a wide-ranging application as an anti-inflammatory treatment, through the modulation of the production of pro-inflammatory cytokines. Click here Tamboran Resources Ltd (ASX:TBN) has signed a Memorandum of Understanding (MoU) with Jemena Ltd to secure access to the Northern Gas Pipeline (NGP) for the company’s proposed 100 TJ per day Maverick Pilot Development in the core of Beetaloo Sub-Basin within the Northern Territory. Click here Surefire Resources NL (ASX:SRN) has advanced exploration and infill...

Continue reading

EQUASENS (ex Pharmagest Interactive) joins Euronext’s new TECH LEADERS segment

                                            Villers-lès-Nancy, 27 June 2022 – 7:00 a.m. (CET) PRESS RELEASE EQUASENS (formerly PHARMAGEST INTERACTIVE) joins Euronext’s new TECH LEADERS segment Equasens Group (Euronext Paris™ – Compartment A – ISIN: FR0012882389) is proud to be included in the new market segment of Euronext Paris: the Euronext Tech Leaders, a selection of 100+ high-growth European technology companies. The new Tech Leaders were selected from an ecosystem of 700 technology companies listed on Euronext markets, based on their technological leadership, market capitalisation and growth profile. Thierry CHAPUSOT, Chairman of the Board of Directors of Equasens Group, commenting on this development stated: “We are very proud to have been selected by Euronext to join this new segment. Equasens Group, and all its...

Continue reading

Voltalia is developing a new renewable solar cluster in southeastern Brazil

Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energies, announces the development of a new photovoltaic cluster with a potential capacity of more than 1.5 gigawatts in the state of Minas Gerais. After developing its large clusters in Brazil at Serra Branca1 (potential of 2.4 gigawatts, in the state of Rio Grande do Norte) and Canudos2 (potential of more than 1 gigawatt, in the state of Bahia), Voltalia is developing Arinos, a new solar cluster with a potential of more than 1.5 gigawatts, this time located in the southeast of the country. With the Arinos cluster, Voltalia is developing for its own account and also for third parties. Voltalia has already signed partnerships, notably with CTG Brasil, a reference in clean energy in the country. Following approvals, these partners will purchase a significant...

Continue reading

Basilea reports progress on the implementation of its strategy to focus on anti-infectives

ERADICATE phase 3 study exploring ceftobiprole for the treatment of patients with Staphylococcus aureus bacteremia (SAB) expected to report results shortly Separate transactions for TTK/PLK1 inhibitor (BAL0891) and preclinical oncology projects expected to be concluded in H2 2022 No expansion of ongoing lisavanbulin clinical studies; exploring partnering opportunities Derazantinib rights to be transferred back to Merck & Co. by the end of 2022 No material expenses related to oncology activities beyond 2022 and sustainable profitability expected in 2023 Strategy implementation on trackAd hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, June 27, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today an update on the progress made in the implementation of its...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.